ABIO
Dr. Michael R. Bristow M.D., Ph.D. - Co-Founder, Chief Exec. Officer, Pres and Director of ARCA biopharma, Inc.

Person placeholder

Dr. Michael R. Bristow M.D., Ph.D.

Co-Founder, Chief Exec. Officer, Pres and Director

Total compensation: $402,563
Age: 73
ARCA biopharma, Inc. logo

ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator, which is in clinical trial for the treatment of atrial fibrillation in chronic heart failure patients with reduced left ventricular ejection fraction. The company has a collaboration agreement with Medtronic, Inc. for the support of GENETIC-AF Phase 2B/Phase 3 clinical trials; and Laboratory Corporation of America to provide the companion diagnostic test and services to support GENETIC-AF trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.

  • ARCA biopharma, Inc., 11080 CirclePoint Road, Westminster 80020, United States
  • arcabiopharma.com
  • 720-940-2200
Messenger